Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis

Andrew Harold Limper, Thomas V. Colby, Malcolm S. Sanders, Shoji Asakura, Patrick C. Roche, Richard A. Deremee

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Sarcoidosis is a chronic inflammatory disease of unknown cause characterized by the formation of nonnecrotizing granulomas in affected tissues, most notably the lungs. Granuloma healing may result in pulmonary fibrosis and respiratory impairment in some patients. Transforming growth factor-β1 (TGF-β1) is a potent cytokine that promotes fibrosis by enhancing the synthesis of extracellular matrix components, including fibronectin and the α5β1 fibronectin receptor. The role of TGF-β1 in promoting lung fibrosis in the setting of pulmonary sarcoidosis has not yet been investigated. Accordingly, we determined the extent and distribution of TGF-β1 in lung tissue obtained from seven patients with clinical and histologic features of pulmonary sarcoidosis. The tissue distributions of TGF-β1, the TGF-β1 binding proteoglycan decorin, fibronectin, and the α5β1 fibronectin receptor were assessed immunohistochemically. In all cases, the epithelioid histiocytes comprising nonnecrotizing granulomas of pulmonary sarcoidosis contained abundant TGF-β1. We further demonstrated decorin, fibronectin, and the α5β1 fibronectin receptor within nonnecrotizing granulomas and in the fibrous tissue surrounding the lesions. TGF-β1 staining was also observed in bronchiolar epithelial cells, hyperplastic Type II pneumocytes, and occasional alveolar macrophages. This study demonstrates enhanced tissue localization of TGF-β1 and related extracellular matrix proteins associated with the nonnecrotizing granulomas of pulmonary sarcoidosis. Through its actions on matrix protein synthesis, TGF-β1 may modulate the fibrotic repair process accompanying granuloma healing in sarcoidosis.

Original languageEnglish (US)
Pages (from-to)197-204
Number of pages8
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume149
Issue number1
StatePublished - Jan 1994

Fingerprint

Pulmonary Sarcoidosis
Transforming Growth Factors
Granuloma
Integrin alpha5beta1
Fibronectins
Decorin
Sarcoidosis
Lung
Fibrosis
Alveolar Epithelial Cells
Histiocytes
Pulmonary Fibrosis
Extracellular Matrix Proteins
Alveolar Macrophages
Tissue Distribution
Proteoglycans
Extracellular Matrix
Chronic Disease
Epithelial Cells
Staining and Labeling

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. / Limper, Andrew Harold; Colby, Thomas V.; Sanders, Malcolm S.; Asakura, Shoji; Roche, Patrick C.; Deremee, Richard A.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 149, No. 1, 01.1994, p. 197-204.

Research output: Contribution to journalArticle

Limper, Andrew Harold ; Colby, Thomas V. ; Sanders, Malcolm S. ; Asakura, Shoji ; Roche, Patrick C. ; Deremee, Richard A. / Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. In: American Journal of Respiratory and Critical Care Medicine. 1994 ; Vol. 149, No. 1. pp. 197-204.
@article{4c804d85e4394c0585c98688f05c92c4,
title = "Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis",
abstract = "Sarcoidosis is a chronic inflammatory disease of unknown cause characterized by the formation of nonnecrotizing granulomas in affected tissues, most notably the lungs. Granuloma healing may result in pulmonary fibrosis and respiratory impairment in some patients. Transforming growth factor-β1 (TGF-β1) is a potent cytokine that promotes fibrosis by enhancing the synthesis of extracellular matrix components, including fibronectin and the α5β1 fibronectin receptor. The role of TGF-β1 in promoting lung fibrosis in the setting of pulmonary sarcoidosis has not yet been investigated. Accordingly, we determined the extent and distribution of TGF-β1 in lung tissue obtained from seven patients with clinical and histologic features of pulmonary sarcoidosis. The tissue distributions of TGF-β1, the TGF-β1 binding proteoglycan decorin, fibronectin, and the α5β1 fibronectin receptor were assessed immunohistochemically. In all cases, the epithelioid histiocytes comprising nonnecrotizing granulomas of pulmonary sarcoidosis contained abundant TGF-β1. We further demonstrated decorin, fibronectin, and the α5β1 fibronectin receptor within nonnecrotizing granulomas and in the fibrous tissue surrounding the lesions. TGF-β1 staining was also observed in bronchiolar epithelial cells, hyperplastic Type II pneumocytes, and occasional alveolar macrophages. This study demonstrates enhanced tissue localization of TGF-β1 and related extracellular matrix proteins associated with the nonnecrotizing granulomas of pulmonary sarcoidosis. Through its actions on matrix protein synthesis, TGF-β1 may modulate the fibrotic repair process accompanying granuloma healing in sarcoidosis.",
author = "Limper, {Andrew Harold} and Colby, {Thomas V.} and Sanders, {Malcolm S.} and Shoji Asakura and Roche, {Patrick C.} and Deremee, {Richard A.}",
year = "1994",
month = "1",
language = "English (US)",
volume = "149",
pages = "197--204",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

TY - JOUR

T1 - Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis

AU - Limper, Andrew Harold

AU - Colby, Thomas V.

AU - Sanders, Malcolm S.

AU - Asakura, Shoji

AU - Roche, Patrick C.

AU - Deremee, Richard A.

PY - 1994/1

Y1 - 1994/1

N2 - Sarcoidosis is a chronic inflammatory disease of unknown cause characterized by the formation of nonnecrotizing granulomas in affected tissues, most notably the lungs. Granuloma healing may result in pulmonary fibrosis and respiratory impairment in some patients. Transforming growth factor-β1 (TGF-β1) is a potent cytokine that promotes fibrosis by enhancing the synthesis of extracellular matrix components, including fibronectin and the α5β1 fibronectin receptor. The role of TGF-β1 in promoting lung fibrosis in the setting of pulmonary sarcoidosis has not yet been investigated. Accordingly, we determined the extent and distribution of TGF-β1 in lung tissue obtained from seven patients with clinical and histologic features of pulmonary sarcoidosis. The tissue distributions of TGF-β1, the TGF-β1 binding proteoglycan decorin, fibronectin, and the α5β1 fibronectin receptor were assessed immunohistochemically. In all cases, the epithelioid histiocytes comprising nonnecrotizing granulomas of pulmonary sarcoidosis contained abundant TGF-β1. We further demonstrated decorin, fibronectin, and the α5β1 fibronectin receptor within nonnecrotizing granulomas and in the fibrous tissue surrounding the lesions. TGF-β1 staining was also observed in bronchiolar epithelial cells, hyperplastic Type II pneumocytes, and occasional alveolar macrophages. This study demonstrates enhanced tissue localization of TGF-β1 and related extracellular matrix proteins associated with the nonnecrotizing granulomas of pulmonary sarcoidosis. Through its actions on matrix protein synthesis, TGF-β1 may modulate the fibrotic repair process accompanying granuloma healing in sarcoidosis.

AB - Sarcoidosis is a chronic inflammatory disease of unknown cause characterized by the formation of nonnecrotizing granulomas in affected tissues, most notably the lungs. Granuloma healing may result in pulmonary fibrosis and respiratory impairment in some patients. Transforming growth factor-β1 (TGF-β1) is a potent cytokine that promotes fibrosis by enhancing the synthesis of extracellular matrix components, including fibronectin and the α5β1 fibronectin receptor. The role of TGF-β1 in promoting lung fibrosis in the setting of pulmonary sarcoidosis has not yet been investigated. Accordingly, we determined the extent and distribution of TGF-β1 in lung tissue obtained from seven patients with clinical and histologic features of pulmonary sarcoidosis. The tissue distributions of TGF-β1, the TGF-β1 binding proteoglycan decorin, fibronectin, and the α5β1 fibronectin receptor were assessed immunohistochemically. In all cases, the epithelioid histiocytes comprising nonnecrotizing granulomas of pulmonary sarcoidosis contained abundant TGF-β1. We further demonstrated decorin, fibronectin, and the α5β1 fibronectin receptor within nonnecrotizing granulomas and in the fibrous tissue surrounding the lesions. TGF-β1 staining was also observed in bronchiolar epithelial cells, hyperplastic Type II pneumocytes, and occasional alveolar macrophages. This study demonstrates enhanced tissue localization of TGF-β1 and related extracellular matrix proteins associated with the nonnecrotizing granulomas of pulmonary sarcoidosis. Through its actions on matrix protein synthesis, TGF-β1 may modulate the fibrotic repair process accompanying granuloma healing in sarcoidosis.

UR - http://www.scopus.com/inward/record.url?scp=0028154068&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028154068&partnerID=8YFLogxK

M3 - Article

C2 - 8111583

AN - SCOPUS:0028154068

VL - 149

SP - 197

EP - 204

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -